These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy. Heresbach D; Raoul JL; Bretagne JF; Minet J; Donnio PY; Ramée MP; Siproudhis L; Gosselin M Gut; 1992 Dec; 33(12):1608-11. PubMed ID: 1487160 [TBL] [Abstract][Full Text] [Related]
23. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. Morgner A; Bayerdörffer E; Neubauer A; Stolte M Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075 [TBL] [Abstract][Full Text] [Related]
24. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review. Xia D; Morgan EA; Berger D; Pinkus GS; Ferry JA; Zukerberg LR Am J Clin Pathol; 2019 Jan; 151(1):75-85. PubMed ID: 30212873 [TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma. Park JB; Koo JS World J Gastroenterol; 2014 Mar; 20(11):2751-9. PubMed ID: 24659867 [TBL] [Abstract][Full Text] [Related]
26. Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders. Hue SS; Ng SB; Wang S; Tan SY Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626087 [TBL] [Abstract][Full Text] [Related]
27. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy. Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157 [TBL] [Abstract][Full Text] [Related]
28. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M; Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816 [TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study. Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216 [TBL] [Abstract][Full Text] [Related]
30. A case of excisionally remitted indolent NK-cell enteropathy in the oral cavity and a mini-review. Li X; Li Z; Zhou X; Zheng Y; Zhang Y; Xie J J Cutan Pathol; 2024 Jul; 51(7):518-524. PubMed ID: 38642003 [TBL] [Abstract][Full Text] [Related]
31. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118 [TBL] [Abstract][Full Text] [Related]
32. Regression of MALT lymphomas coexisting in the duodenal bulb and the stomach by eradication of Helicobacter pylori. Hori K; Nishigami T; Chiba T; Matsushima Y; Kojima T J Gastroenterol; 2002; 37(4):288-92. PubMed ID: 11993513 [TBL] [Abstract][Full Text] [Related]
34. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases. Begum S; Sano T; Endo H; Kawamata H; Urakami Y J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978 [TBL] [Abstract][Full Text] [Related]
35. [Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma]. Ota H; Asano N; Yamauchi K; Akamatsu T Rinsho Byori; 2009 Sep; 57(9):861-9. PubMed ID: 19860212 [TBL] [Abstract][Full Text] [Related]
36. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Nakajima S; Graham DY; Hattori T; Bamba T Curr Pharm Des; 2000 Oct; 6(15):1503-14. PubMed ID: 10974147 [TBL] [Abstract][Full Text] [Related]
37. Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level. Iijima K; Ara N; Abe Y; Koike T; Iwabuchi T; Shinkai H; Uno K; Endo H; Asano N; Shimosegawa T J Gastroenterol; 2012 Dec; 47(12):1290-7. PubMed ID: 22549566 [TBL] [Abstract][Full Text] [Related]
38. Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract. Maguilnik I; Neumann WL; Sonnenberg A; Genta RM Aliment Pharmacol Ther; 2012 Oct; 36(8):736-43. PubMed ID: 22928604 [TBL] [Abstract][Full Text] [Related]
39. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach. Ferreri AJ; Govi S; Ponzoni M Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292 [TBL] [Abstract][Full Text] [Related]
40. Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma. De Vita S; Ferraccioli G; Avellini C; Sorrentino D; Dolcetti R; Di Loreto C; Bartoli E; Boiocchi M; Beltrami CA Gastroenterology; 1996 Jun; 110(6):1969-74. PubMed ID: 8964425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]